Read + Share
Amedeo Smart
Independent Medical Education
Qian CS, Ma X, Wang J, Wang TJ, et al. PD1 inhibitor in combination with 5-azacytidine and low-dose DLI for the successful treatment of AML patients who relapsed after transplantation. Bone Marrow Transplant 2021;56:1003-1005.PMID: 33214690
Email
LinkedIn
Facebook
Twitter
Privacy Policy